A Pituitary Society update to acromegaly management guidelines.
Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L, Molitch ME, Samson SL, Strasburger CJ, van der Lely AJ, Melmed S.
Pituitary. 2021 Feb;24(1):1-13. doi: 10.1007/s11102-020-01091-7. Epub 2020 Oct 20.
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
Boguszewski MCS, Boguszewski CL, Chemaitilly W, Cohen LE, Gebauer J, Higham C, Hoffman AR, Polak M, Yuen KCJ, Alos N, Antal Z, Bidlingmaier M, Biller BMK, Brabant G, Choong CSY, Cianfarani S, Clayton PE, Coutant R, Cardoso-Demartini AA, Fernandez A, Grimberg A, Guðmundsson K, Guevara-Aguirre J, Ho KKY, Horikawa R, Isidori AM, Jørgensen JOL, Kamenicky P, Karavitaki N, Kopchick JJ, Lodish M, Luo X, McCormack AI, Meacham L, Melmed S, Mostoufi Moab S, Müller HL, Neggers SJCMM, Aguiar Oliveira MH, Ozono K, Pennisi PA, Popovic V, Radovick S, Savendahl L, Touraine P, van Santen HM, Johannsson G.
Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. doi: 10.1530/EJE-21-1186.
Acromegaly.
Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R.
Nat Rev Dis Primers. 2019 Mar 21;5(1):20. doi: 10.1038/s41572-019-0071-6.
Growth Hormone: Therapeutic Possibilities-An Overview.
Harvey S, Martinez-Moreno CG.
Int J Mol Sci. 2018 Jul 11;19(7):2015. doi: 10.3390/ijms19072015.
The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
Jasim S, Alahdab F, Ahmed AT, Tamhane SU, Sharma A, Donegan D, Nippoldt TB, Murad MH.
Endocrine. 2017 May;56(2):267-278. doi: 10.1007/s12020-016-1156-6. Epub 2016 Nov 4.
Growth hormone in the tumor microenvironment.
Chesnokova V, Melmed S.
Arch Endocrinol Metab. 2019 Nov-Dec;63(6):568-575. doi: 10.20945/2359-3997000000186.
Growth hormone after CNS tumor diagnosis: the fundamentals, fears, facts, and future directions.
Ronsley R, Lazow M, Henry RK.
Pediatr Hematol Oncol. 2023;40(8):786-799. doi: 10.1080/08880018.2023.2190765. Epub 2023 Mar 20.
Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
Losa M, Gatti E, Rossini A, Lanzi R.
J Endocrinol Invest. 2008 Sep;31(9 Suppl):75-8.
Growth Hormone Excess: Implications and Management.
Dhaneshwar S, Shandily S, Tiwari V.
Endocr Metab Immune Disord Drug Targets. 2023;23(6):748-763. doi: 10.2174/1871530322666221012155533.
Growth and Growth Hormone through the Ages: Art and Science.
Rogol AD, Reiter EO.
Horm Res Paediatr. 2022;95(6):515-528. doi: 10.1159/000526440. Epub 2022 Nov 29.
